Data protection Impressum

Medical Devices

Burgdorf-based medtech Ypsomed has announced the sale of its diabetes care business to TecMed AG for up to CHF 420 million. The move marks a significant strategic shift, positioning Ypsomed as a pure-play provider of self-injection systems for pharmaceutical and biotech partners worldwide.

Bern-based Ypsomed pivots with CHF 420 million diabetes unit sale to TecMed

23 April 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (April 2025)

23 April 2025

A new privately funded health innovation campus will take shape in Meyrin, combining clinical care, research, and industry in one integrated ecosystem.

Campus Santé, a landmark investment in Geneva’s future of healthcare and research

7 April 2025

With over 30 years of presence in Le Locle, Jabil has established itself as a key player in Neuchâtel’s advanced manufacturing landscape.

Jabil, driving medical innovation from the heart of Neuchâtel’s industrial ecosystem

2 April 2025

Bern-based medtech company machineMD has announced a strategic partnership with Topcon Healthcare. The collaboration aims to integrate machineMD’s neurodiagnostic technology with Topcon’s digital health platform, paving the way for earlier and more precise detection of neurological diseases within a connected care ecosystem.

Neurodiagnostics specialist machineMD secures strategic investment from Topcon Healthcare

24 March 2025

The Foundation for Technological Innovation (FIT) has awarded funding to promising Western Switzerland start-ups PeriVision, Bioscibex, and Carewell, to accelerate their development in healthtech and biotechnology.

Western Switzerland innovators PeriVision, Bioscibex and Carewell receive support from FIT

17 March 2025

A research team at .NeuroRestore (EPFL/CHUV/UNIL) has developed an innovative rehabilitation approach that combines robotic-assisted therapy with spinal cord stimulation, offering new hope for individuals with spinal cord injuries.

.NeuroRestore’s breakthrough in robotics and spinal stimulation restores mobility after paralysis

17 March 2025

Lausanne-based Limula has introduced LimONE, a fully automated cell therapy manufacturing platform designed to streamline production, reduce costs, and improve accessibility for patients. The company expects to deliver the first units by 2028.

Limula unveils LimONE, a breakthrough in automated cell therapy manufacturing

10 March 2025

Innovaud has awarded the Scale-Up Vaud 2025 label to 42 high-growth companies, including nine new entrants, reinforcing the region’s dynamic innovation ecosystem.

42 Vaud-based companies awarded Scale-Up Vaud 2025 label

3 March 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (February 2025)

25 February 2025

1 2 3 4 5 … 11